SARCLISA is a targeted monoclonal antibody given with other medicines for adults with previously treated multiple myeloma. See full Safety & Prescribing ...
People also ask
What is SARCLISA used for?
Is SARCLISA a chemo?
Who manufactures SARCLISA?
Is isatuximab chemotherapy or immunotherapy?
Information for HCPs about SARCLISA (isatuximab-irfc), a therapy for relapsed or refractory multiple myeloma. See Important Safety & Prescribing Info.
Sarclisa® is a novel anti-CD38 monoclonal antibody. It is a type of targeted immunotherapy that is able to “find and bind” to myeloma cells.
SARCLISA is a CD38-directed cytolytic antibody indicated: • in combination with pomalidomide and dexamethasone, for the treatment of adult patients with ...
SARCLISA is indicated, in combination with pomalidomide and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least ...
6 days ago · Sarclisa is a monoclonal antibody that binds to a specific epitope on the CD38 receptor on multiple myeloma (MM) cells, inducing distinct ...
Find Out if SARCLISA Could Be an Option for You or Your Loved One. Learn More Today. Learn More About Treatment With...
See the Patient Characteristics for Both Treatment Arms for Both Studies. Learn How SARCLISA Was Studied in Both Phase 3 Trials. FDA-Approved. Contact Your Rep.